The regulatory woes are hitting Massachusetts. Lawmakers in the Bay State have been trying to amend the voter approved recreational cannabis legalization law since it passed in November, and the lack of clarity is now taking a toll on the state’s existing medical marijuana community.

According to the Boston Globe, municipalities across Massachusetts are slow to approve medical marijuana permits thanks to the uncertainty surrounding the state’s recreational law. As the law currently stands, once recreational sales are approved, medical dispensaries will be able to sell to the age-approved general public without any additional permits or licenses.

Mass.

This June, Ohio's medical marijuana law came into effect, with plans to be fully operational by next September. However, the state has some of the highest fees of any MMJ-legal state, which has drawn criticism from some state regulators.

Ohio is offering 24 licenses to cultivators, 40 to product processors, and 60 to dispensaries. The fee for applying for any medical marijuana license is a non-refundable $2,000, and growers must pay an additional license fee of $18,000 to $180,000 depending on the size of the grow-op.

Payment processing companies like PayPal, Square, and Stripe have been purging marijuana-related companies since the beginning of the year. The purge seems to be in response to Attorney General Jeff Sessions' most recent threat of cracking down on the legal marijuana industry. Canna-biz startups ranging from vape pen manufacturers to marijuana business software companies are now forced to scramble to find new methods of handling their payments.

Boston-based startup Ardent, manufacturer of a federally legal decarboxylator used to make marijuana edibles, was bounced from at least seven different payment processors.

It is possible that Congress could decide this year to repeal on old federal law designed to persuade states to suspend the driving privileges of convicted drug offenders.

Earlier last week, Representative Beto O’Rourke of Texas introduced a piece of legislation in the U.S. House of Representatives that would eliminate a U.S.

Rhode Island has had one of the more comprehensive medical marijuana programs on the East Coast for more than 10 years. But with eight states legalizing recreational adult cannabis use, and neighboring Massachusetts set to cash in next year, lawmakers in Rhode Island are trying their best to make sure they don’t miss the boat.

As the Democrat-controlled Rhode Island General Assembly prepares to start their spring session, Rep.

Oregon’s recreational cannabis system has had an enormous impact on the local economy. While lawmakers valiantly attempt to shield their booming market from federal law enforcement, there are some things that just can’t be protected against so long as marijuana remains classified as a Schedule 1 drug.

One of those disadvantages is trouble securing loans from financial institutions. Since cannabis remains illegal under federal law, marijuana-related businesses have been shunned from most federally-regulated banks and credit unions.

Last week, America had all eyes glued on the FBI’s probe into Donald Trump’s increasingly sketchy ties with the Russian government. But a slew of new controversy has flooded the administration since, from the Republicans’ decision to go "nuclear" in order to confirm Supreme Justice Neil Gorsuch, to the frightening possibility of a new war in the Middle East. There’s been an increasing amount hypocrisy brewing in both the White House and Senate, creating an air of uncertainty across the country.

Voters in Nevada legalized recreational cannabis last November with plans to start recreational sales at the beginning of 2018.

House Bill 2020, introduced to Congress on Thursday, would finally remove cannabis from its current standing as a Schedule I narcotic, and reclassify it as Schedule III drug with an accepted medical value.

According to the DEA, Schedule III drugs are those with “a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.”

Current Schedule III substances include Tylenol with Codeine, ketamine and anabolic steroids.

The rescheduling bill is the brainchild of Republican Rep. Matt Gaetz and Democratic Rep. Darren Soto.

Although it has been said that Indiana would be one of the last states to put any kind of marijuana law on the books, both chambers of the State Legislature took action this week on a bill aimed at allowing a specific group of patients to have access to non-intoxicating cannabis oil.

On Thursday, both the House and Senate put their seal of approval on proposals designed to give epilepsy patients the freedom to use cannabidiol (CBD), a cannabis derivative that has been shown to decrease the frequency of seizures.